{
    "clinical_study": {
        "@rank": "45064", 
        "brief_summary": {
            "textblock": "Contrast enhanced EUS with the sonographic contrast agent DEFINITY\u2122 has the potential to\n      detect pancreatic cancer at an earlier stage, to improve current method of T staging and\n      assessment of surgical resectability and also to distinguish between benign and malignant\n      pancreatic masses. All these will translate into better clinical outcome, and also avoid\n      unnecessary surgery in situations of unresectable cancers."
        }, 
        "brief_title": "Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses", 
        "completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "condition": "Pancreatic Cancer", 
        "condition_browse": {
            "mesh_term": "Pancreatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Consecutive patients over a 1-year period referred for EUS examination due to\n             suspected pancreatic lesions will be enrolled.\n\n          -  Age 21 years and above.\n\n          -  Ability to provide informed consent\n\n        Exclusion Criteria:\n\n        Patients with clinical conditions that preclude the use of DEFINITY\u2122 will be excluded.\n        These conditions are:\n\n          -  Right-to-left, bi-directional, or transient right-to-left cardiac shunts;\n\n          -  Worsening or clinically unstable congestive heart failure;\n\n          -  Acute myocardial infarction or acute coronary syndromes;\n\n          -  Serious ventricular arrhythmias or high risk for arrhythmias due to prolongation of\n             the QT interval;\n\n          -  Respiratory failure;\n\n          -  Severe emphysema, pulmonary emboli or other conditions that cause pulmonary\n             hypertension due to compromised pulmonary arterial vasculature;\n\n          -  Hypersensitivity to DEFINITY\u2122 or its components."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "A total of 50 subjects will be enrolled. The study population will be drawn from patients\n        referred for EUS evaluation on basis of suspected pancreatic cancer. These patients could\n        be either from clinics or from the hospital wards."
            }
        }, 
        "enrollment": {
            "#text": "33", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703026", 
            "org_study_id": "CTC0900328"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 9, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Singapore", 
                    "country": "Singapore"
                }, 
                "name": "Changi General Hospital"
            }
        }, 
        "location_countries": {
            "country": "Singapore"
        }, 
        "number_of_groups": "1", 
        "official_title": "Contrast Enhanced EUS Using Definity in the Evaluation of Pancreatic Cancer and Pancreatic Masses", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Singapore: Health Sciences Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "17580363", 
                "citation": "Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007 Aug 15;110(4):738-44."
            }, 
            {
                "PMID": "18956589", 
                "citation": "Ang TL. Endoscopic ultrasound: moving from diagnostics to therapeutics. J Dig Dis. 2008 Aug;9(3):117-28. Review."
            }, 
            {
                "PMID": "1612375", 
                "citation": "Snady H, Cooperman A, Siegel J. Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointest Endosc. 1992 Jan-Feb;38(1):27-34."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703026"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Changi General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Changi General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}